PT-141 Dosage and Reconstitution Guide: 10 mg Vial Math, Timing, Cost, and Buyer Checks
PT-141 buyers need to separate the studied 1.75 mg bremelanotide reference dose from research-vial concentration math. This guide covers timing, 10 mg reconstitution examples, current cost per 1.75 mg equivalent, and the COA checks to make before buying.
Short Answer: Start With the Studied 1.75 mg Reference, Then Check the Vial Math
The clearest clinical anchor for PT-141 dosing is Vyleesi, the regulated bremelanotide product: 1.75 mg in 0.3 mL, used as needed at least 45 minutes before anticipated sexual activity. That label is the reference point for every number in this guide, and it comes with a caveat that matters more than any forum protocol: the same active peptide name does not mean a lyophilized research vial shares the regulated product's formulation, concentration, delivery system, sterility assurance, or batch evidence.
For a 10 mg research vial, the buying workflow that actually protects you runs in this order: verify exact PT-141 (bremelanotide) identity on a lot-matched COA, choose a final water volume that fits your vial, run the concentration math at /tools/reconstitution-calculator, compare live price per mg at /prices/pt-141, and inspect seller evidence at /vendors.
One piece of math anchors everything below: a 10 mg vial contains 10,000 mcg. The amount of bacteriostatic water you add changes the concentration and the syringe units per dose. It never changes the total 10 mg in the vial.
What the FDA Label and Phase 3 Trials Actually Studied
The FDA label recommends 1.75 mg subcutaneously in the abdomen or thigh, as needed, at least 45 minutes before anticipated sexual activity. The labeled product is a single-dose 1.75 mg/0.3 mL autoinjector. The label caps use at no more than one dose in 24 hours and no more than eight doses per month, and it states plainly that the duration of efficacy and the optimal administration window have not been fully characterized.
The evidence behind that label is real. The two randomized, double-blind, placebo-controlled RECONNECT Phase 3 trials enrolled more than 1,200 premenopausal women with acquired generalized hypoactive sexual desire disorder and used 1.75 mg as needed for 24 weeks (PMID 31599840). About 25 percent of bremelanotide users achieved a meaningful sexual-desire score response versus about 17 percent with placebo, with a significant reduction in distress related to low desire.
On timing: mean terminal half-life after a single subcutaneous dose was about 2.7 hours, with a range of 1.9 to 4.0 hours. Resist converting half-life into a promise about onset or subjective duration. The label's own language does not.
10 mg PT-141 Reconstitution Math
Treat these as arithmetic examples tied to the 1.75 mg regulated-product reference, not personalized prescribing instructions. A U-100 insulin syringe holds 100 units per mL, so one unit equals 0.01 mL.
With 1 mL of bacteriostatic water: 10 mg/mL, 100 mcg per unit, and 1.75 mg is 0.175 mL, or 17.5 units. With 2 mL: 5 mg/mL, 50 mcg per unit, and 1.75 mg is 0.35 mL, or 35 units. With 2.5 mL: 4 mg/mL, 40 mcg per unit, and 1.75 mg is 0.4375 mL, or 43.75 units. With 3 mL: about 3.333 mg/mL, about 33.33 mcg per unit, and 1.75 mg is 0.525 mL, or 52.5 units.
Before trusting any row, verify your vial's actual capacity, your final volume, any product-specific diluent directions, and your syringe markings. The calculator at /tools/reconstitution-calculator runs any combination live, /blog/10mg-peptide-vial-reconstitution-chart is the broader reference table, and /blog/peptide-reconstitution-bac-water-buyer-guide covers the water itself.
How Many 1.75 mg Equivalents Fit in a 10 mg Vial
Ten milligrams divided by 1.75 mg is 5.714, so a 10 mg vial holds five complete 1.75 mg amounts, using 8.75 mg, with 1.25 mg left before handling loss. Six complete amounts would require 10.5 mg. This is vial arithmetic, not a recommendation to use the full vial or to adopt the Vyleesi schedule with a research product.
Water volume has no effect on this count. Bacteriostatic water changes concentration, draw volume, and syringe units; the theoretical number of dose equivalents is fixed by the milligrams in the vial. Use /tools/cost-per-dose to compare per-dose economics, but only after vial identity, size, lot evidence, and delivered price are actually comparable.
Current PT-141 Prices and Cost Per 1.75 mg Equivalent
PeptidePub's catalog snapshot on September 1, 2026, all 10 mg listings: Double R $29.99, Viper $29.99, Atomik $37, Peptide Society $39.99, Glacier $40.99, Valor $43.99, AMP $44, EZ Peptides $44, Mile High $44.99, Ascension $49, Main Peptides $49.99, Valkyrie $50, Improved Peptides $65, and World Wide Peptides $141.
That is a list-price range of $29.99 to $141 per 10 mg vial, roughly $3.00 to $14.10 per labeled mg. A theoretical 1.75 mg material amount therefore costs about $5.25 to $24.68 before shipping, tax, discounts, and handling loss. Selected list-price costs per 1.75 mg: Double R or Viper $5.25, Atomik $6.48, Peptide Society $7.00, Glacier $7.17, Valor $7.70, AMP or EZ $7.70, Mile High $7.87, Ascension $8.58, Main $8.75, Valkyrie $8.75, Improved $11.38, and World Wide $24.68.
Verified Discount Codes Change the Ranking
Ascension's 50 percent code PEPTIDEPUB drops $49 to $24.50, about $2.45 per mg or $4.29 per 1.75 mg, the strongest verified value in the snapshot. Double R and Viper at 15 percent with PEPTIDEPUB come to about $25.49, $2.55 per mg or $4.46 per 1.75 mg. Peptide Society at 20 percent with PEPTIDEPUB is about $31.99, $3.20 per mg or $5.60 per 1.75 mg. Atomik at 15 percent with PEPTIDEPUB15 is $31.45, about $3.15 per mg or $5.50 per 1.75 mg.
Prices and codes move constantly. Check /prices/pt-141 and /deals before checkout, and rank value by delivered cost per verified milligram, not sticker price.
Side-Effect and Product-Proof Checks Before Buying
The labeled product's trial numbers are the best available preview of tolerability. Nausea occurred in 40 percent of Vyleesi users, 13 percent used antiemetic treatment, and nausea drove discontinuation in 8 percent. Other reactions above 4 percent included flushing, injection-site reactions, headache, and vomiting. The label also warns of a transient blood-pressure increase and heart-rate decrease after dosing, generally resolving within about 12 hours, which is why uncontrolled hypertension or known cardiovascular disease are contraindications. Focal hyperpigmentation occurred in 1 percent of patients receiving up to eight monthly doses.
What a Strong COA Looks Like for PT-141
A research-vial COA should match PT-141 or bremelanotide by name, the exact batch or lot, the vial size, and the current product. Require named-lab identity, purity, and quantitative content testing. For an injectable format, stronger evidence adds sterility, endotoxin, heavy-metal, and contaminant checks.
A 99 percent purity result does not prove a vial contains 10 mg. A cheap vial without verified net content cannot be cleanly compared with one that has batch-matched fill data. The full walkthrough lives at /blog/how-to-read-peptide-coa-before-you-buy, and vendor-by-vendor testing evidence at /vendors.
FAQ
What is the studied PT-141 dose? The FDA-labeled Vyleesi reference is 1.75 mg subcutaneously, as needed, at least 45 minutes before anticipated sexual activity. That applies to the regulated 1.75 mg/0.3 mL autoinjector and does not validate an unverified research vial.
How many units is 1.75 mg from a 10 mg vial? It depends on final volume: 17.5 U-100 units at 1 mL, 35 units at 2 mL, 43.75 units at 2.5 mL, or 52.5 units at 3 mL.
How many 1.75 mg amounts are in 10 mg? Mathematically 5.714, which means five complete 1.75 mg amounts with 1.25 mg left over before handling loss. Six would require 10.5 mg.
How often was the regulated product used? The label caps use at one dose in 24 hours and eight doses per month. Do not convert that into a universal research-vial schedule.
What should a PT-141 buyer verify? Exact bremelanotide identity, lot match, named lab, purity, net content, sterility and endotoxin evidence where available, correct vial size, delivered price, and the current code.
Bottom Line
Use the 1.75 mg Vyleesi label as the clinical reference, and keep regulated-product evidence separate from research-vial quality and concentration math. For a 10 mg vial, verify identity and batch proof first, calculate your chosen final concentration at /tools/reconstitution-calculator, compare live pricing at /prices/pt-141, inspect seller evidence at /vendors, and apply /deals only after the evidence matches. Background on the compound lives at /peptides/pt-141 and the broader /blog/pt-141-buyer-guide.
The strongest PT-141 purchase combines exact identity, credible lot-specific testing, correct concentration math, and the lowest delivered cost per verified milligram. When everything checks out, /go/bodybuilding-health is the action route.
Follow @PeptidePub on X for daily peptide price drops.
Get peptide price-drop alerts
Set a target price and we'll email you when a trusted, third-party-tested vendor drops below it. No spam, unsubscribe anytime.
From the community
Ask a question βRelated Articles
PT-141 Buyer Guide: Libido Peptide Benefits, Melanocortin Checks, Price Per Mg, COAs, and Vendors
10 mg Peptide Vial Reconstitution Chart: BAC Water Math and Syringe Units
Peptide Reconstitution and BAC Water Buyer Guide: Calculator Math, Supply Prices, and Vendor Checks